Sugar Modified Nucleosides and Nucleotides: The Synthesis of Anti-Viral Drugs

In this webinar we cover some of the most important synthetic strategies that allow chemists to make key structural changes to the sugar-portion of nucleosides. The program is focused on the development of experimental nucleoside analogues containing locked nucleic acids for the treatment of HCV and will highlight the problems nucleoside chemists face when working to develop new antiviral drugs.

This program is focused on the development of experimental nucleoside analogues containing locked nucleic acids for the treatment of HCV and will highlight the problems nucleoside chemists face when working to develop new antiviral drugs.

Presented by our experienced chemists the areas of discussions will cover:

  • Looking at the development of experimental nucleoside analogues
  • Nucleic acids for the treatment of HCV
  • Problems nucleoside chemists face when working to develop new antiviral drugs

   This webinar has finished, please click here for free access to the recorded video.

 

Looking for another webinar?